R
Robeauté
Health Tech & Medtech · Paris, France · Founded 2016
We are developing a sub millimetric microrobot that moves in the brain in curved lines (3D) with sub millimetric precision allowing to access complex areas of the brain in multiple locations to gather… MoreLess
Robeauté, founded in 2017 by Joana Cartocci and Bertrand Duplat, is a Paris-based company developing a new class of therapeutic microrobots for neurosurgery.
Duplat's background in robotics, including his work at McGill University, combined with Cartocci's leadership, has positioned the company at the forefront of medical technology. The team is described as multidisciplinary and multicultural, reflecting a global approach to solving complex medical challenges.
The company's core product is a microrobotic platform designed to enhance surgical procedures. These microrobots are engineered for the diagnosis, treatment, and monitoring of the brain, offering a level of flexibility and precision that is not possible with current technologies. The technology is intended to be minimally invasive, allowing access to difficult-to-reach areas of the brain for various therapeutic and diagnostic applications.
Keywords: microrobots, neurosurgery, medical technology, therapeutic applications, diagnostic tools, minimally invasive, brain treatment, robotics, medical devices, surgical procedures
Company overview
Robeauté company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Paris, France
- Employees
- 44
- Open positions
- 11
- Dealroom signal
- 88.2
Valuation & funding
Robeauté funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2025 | $30M | $119M | Brainlab · Cherry Ventures · Kindred Ventures · Plural | ↗ |
| GRANT✓Other financing | Oct 2024 | $2.5M | — | European Innovation Council | — |
| SUPPORT PROGRAM✓Other financing | May 2024 | $0 | — | MedTech Innovator | ↗ |
| SEED✓Equity / VC | Jan 2022 | $3.4M | $14M | APEX Ventures · Urania Ventures | ↗ |
| SUPPORT PROGRAM✓Other financing | Jun 2020 | $44K | — | EIT Health | — |
| SPINOUT✓Other financing | Apr 2016 | SATT LUTECH · Sorbonne University | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
Robeauté website traffic
Latest recorded traffic for Robeauté is 2.3K monthly website visits, up 15% over the last three months. Robeauté's team grew 12.8% over the past year.
Hiring
Open positions at Robeauté
Current openings linked to this company in Dealroom.
Comparisons
Robeauté compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Robeauté's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Robeauté has talent and traffic
team presence
In the news
Latest news about Robeauté
Recent press, funding announcements, and product moves mentioning Robeauté — open to read from the original sources.
Market sentiment
What the market is saying about Robeauté
An AI-synthesized read of the highest-engagement posts about Robeauté on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Robeauté’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.